Skip to main content

Fyarro Prices, Coupons and Patient Assistance Programs

Fyarro (sirolimus protein-bound) is a member of the mTOR inhibitors drug class and is commonly used for Malignant Perivascular Epithelioid Cell Tumor.

The cost for Fyarro intravenous powder for injection 100 mg is around $7,815 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Fyarro prices

Intravenous Powder For Injection

Quantity Per unit Price
1 $7,814.95 $7,814.95

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Fyarro Coupons, Copay Cards and Rebates

Fyarro offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

No manufacturer promotions could be found for this medication.

Patient Assistance & Copay Programs for Fyarro

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: AADIAssist Patient Assistance Program

Eligibility requirements:
  1. Uninsured or Underinsured with no prescription coverage
  2. At or below 400% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be residing in the US.
  5. Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Fyarro (sirolimus albumin-bound nanoparticles) Injection; IV Lyophilized powder

More information please phone: 855-223-4482 Visit Website